Institute of General, Inorganic and Theoretical Chemistry, and Center of Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 80-82, A-6020 Innsbruck, Tyrol, Austria.
J Chem Inf Model. 2020 Apr 27;60(4):2304-2313. doi: 10.1021/acs.jcim.9b01165. Epub 2020 Mar 19.
The use of fragments to biophysically characterize a protein binding pocket and determine the strengths of certain interactions is a computationally and experimentally commonly applied approach. Almost all drug like molecules contain at least one aromatic moiety forming stacking interactions in the binding pocket. In computational drug design, the strength of stacking and the resulting optimization of the aromatic core or moiety is usually calculated using high level quantum mechanical approaches. However, as these calculations are performed in a vacuum, solvation properties are neglected. We close this gap by using Grid Inhomogeneous Solvation Theory (GIST) to describe the properties of individual heteroaromatics and complexes and thereby estimate the desolvation penalty. In our study, we investigated the solvation free energies of heteroaromatics frequently occurring in drug design projects in complex with truncated side chains of phenylalanine, tyrosine, and tryptophan. Furthermore, we investigated the properties of drug-fragments crystallized in a fragment-based lead optimization approach investigating PDE-10-A. We do not only find good correlation for the estimated desolvation penalty and the experimental binding free energy, but our calculations also allow us to predict prominent interaction sites. We highlight the importance of including the desolvation penalty of the respective heteroaromatics in stacked complexes to explain the gain or loss in affinity of potential lead compounds.
使用片段来生物物理地描述蛋白质结合口袋并确定某些相互作用的强度是一种在计算和实验上都广泛应用的方法。几乎所有类似药物的分子都至少含有一个芳基部分,在结合口袋中形成堆积相互作用。在计算药物设计中,通常使用高级量子力学方法来计算堆积的强度以及由此产生的芳基核心或部分的优化。然而,由于这些计算是在真空中进行的,因此忽略了溶剂化性质。我们通过使用网格不均匀溶剂化理论 (GIST) 来描述单个杂芳环和复合物的性质,从而估计去溶剂化罚分,从而弥补了这一差距。在我们的研究中,我们研究了在药物设计项目中经常出现的与苯丙氨酸、酪氨酸和色氨酸的截断侧链复合的杂芳环的溶剂化自由能。此外,我们还研究了在基于片段的先导优化方法中结晶的药物片段的性质,该方法研究了 PDE-10-A。我们不仅发现了估算的去溶剂化罚分与实验结合自由能之间的良好相关性,而且我们的计算还允许我们预测突出的相互作用位点。我们强调了在堆叠复合物中包含相应杂芳环的去溶剂化罚分的重要性,以解释潜在先导化合物亲和力的得失。